PMC:7441788 / 20262-20525 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T111","span":{"begin":134,"end":145},"obj":"Body_part"},{"id":"T112","span":{"begin":221,"end":232},"obj":"Body_part"}],"attributes":[{"id":"A111","pred":"fma_id","subj":"T111","obj":"http://purl.org/sig/ont/fma/fma54878"},{"id":"A112","pred":"fma_id","subj":"T112","obj":"http://purl.org/sig/ont/fma/fma54878"}],"text":" no control HCQ, 200 mg/3 times/day for 10 days combined with azithromycin 500 mg on the 1st day, 250 mg/day afterward for 5 days The nasopharynx viral load in most patients received HCQ decreased rapidly. Observation of nasopharynx viral load. Observational stud"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T10","span":{"begin":134,"end":145},"obj":"Body_part"},{"id":"T11","span":{"begin":221,"end":232},"obj":"Body_part"}],"attributes":[{"id":"A10","pred":"uberon_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/UBERON_0001728"},{"id":"A11","pred":"uberon_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/UBERON_0001728"}],"text":" no control HCQ, 200 mg/3 times/day for 10 days combined with azithromycin 500 mg on the 1st day, 250 mg/day afterward for 5 days The nasopharynx viral load in most patients received HCQ decreased rapidly. Observation of nasopharynx viral load. Observational stud"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T248","span":{"begin":62,"end":74},"obj":"Chemical"}],"attributes":[{"id":"A248","pred":"chebi_id","subj":"T248","obj":"http://purl.obolibrary.org/obo/CHEBI_2955"}],"text":" no control HCQ, 200 mg/3 times/day for 10 days combined with azithromycin 500 mg on the 1st day, 250 mg/day afterward for 5 days The nasopharynx viral load in most patients received HCQ decreased rapidly. Observation of nasopharynx viral load. Observational stud"}

{"project":"LitCovid-sample-MedDRA","denotations":[{"id":"T12","span":{"begin":146,"end":156},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"},{"id":"T13","span":{"begin":233,"end":243},"obj":"http://purl.bioontology.org/ontology/MEDDRA/10022891"}],"attributes":[{"id":"A12","pred":"meddra_id","subj":"T12","obj":"http://purl.bioontology.org/ontology/MEDDRA/10062178"},{"id":"A13","pred":"meddra_id","subj":"T13","obj":"http://purl.bioontology.org/ontology/MEDDRA/10062178"}],"text":" no control HCQ, 200 mg/3 times/day for 10 days combined with azithromycin 500 mg on the 1st day, 250 mg/day afterward for 5 days The nasopharynx viral load in most patients received HCQ decreased rapidly. Observation of nasopharynx viral load. Observational stud"}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T139","span":{"begin":62,"end":74},"obj":"Chemical"}],"attributes":[{"id":"A139","pred":"chebi_id","subj":"T139","obj":"http://purl.obolibrary.org/obo/CHEBI_2955"}],"text":" no control HCQ, 200 mg/3 times/day for 10 days combined with azithromycin 500 mg on the 1st day, 250 mg/day afterward for 5 days The nasopharynx viral load in most patients received HCQ decreased rapidly. Observation of nasopharynx viral load. Observational stud"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T153","span":{"begin":206,"end":244},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" no control HCQ, 200 mg/3 times/day for 10 days combined with azithromycin 500 mg on the 1st day, 250 mg/day afterward for 5 days The nasopharynx viral load in most patients received HCQ decreased rapidly. Observation of nasopharynx viral load. Observational stud"}

{"project":"LitCovid-sample-PD-UBERON","denotations":[{"id":"T9","span":{"begin":134,"end":145},"obj":"Body_part"},{"id":"T10","span":{"begin":221,"end":232},"obj":"Body_part"}],"attributes":[{"id":"A9","pred":"uberon_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/UBERON_0001728"},{"id":"A10","pred":"uberon_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/UBERON_0001728"}],"text":" no control HCQ, 200 mg/3 times/day for 10 days combined with azithromycin 500 mg on the 1st day, 250 mg/day afterward for 5 days The nasopharynx viral load in most patients received HCQ decreased rapidly. Observation of nasopharynx viral load. Observational stud"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T110","span":{"begin":134,"end":145},"obj":"Body_part"},{"id":"T111","span":{"begin":221,"end":232},"obj":"Body_part"}],"attributes":[{"id":"A110","pred":"fma_id","subj":"T110","obj":"http://purl.org/sig/ont/fma/fma54878"},{"id":"A111","pred":"fma_id","subj":"T111","obj":"http://purl.org/sig/ont/fma/fma54878"}],"text":" no control HCQ, 200 mg/3 times/day for 10 days combined with azithromycin 500 mg on the 1st day, 250 mg/day afterward for 5 days The nasopharynx viral load in most patients received HCQ decreased rapidly. Observation of nasopharynx viral load. Observational stud"}

{"project":"LitCovid-sample-PD-MAT","denotations":[{"id":"T6","span":{"begin":134,"end":145},"obj":"http://purl.obolibrary.org/obo/MAT_0000447"},{"id":"T7","span":{"begin":221,"end":232},"obj":"http://purl.obolibrary.org/obo/MAT_0000447"}],"text":" no control HCQ, 200 mg/3 times/day for 10 days combined with azithromycin 500 mg on the 1st day, 250 mg/day afterward for 5 days The nasopharynx viral load in most patients received HCQ decreased rapidly. Observation of nasopharynx viral load. Observational stud"}

{"project":"LitCovid-sentences","denotations":[{"id":"T153","span":{"begin":206,"end":244},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" no control HCQ, 200 mg/3 times/day for 10 days combined with azithromycin 500 mg on the 1st day, 250 mg/day afterward for 5 days The nasopharynx viral load in most patients received HCQ decreased rapidly. Observation of nasopharynx viral load. Observational stud"}